Business Context and Reporting Period
This Form 8-K Current Report was filed by SELLAS Life Sciences Group, Inc. on December 18, 2018, covering events that occurred on December 17, 2018. The filing addresses significant changes in the company's executive leadership, specifically within the finance function.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on personnel changes and associated compensation arrangements.
Material Changes
- Departure of CFO: Gene Mack resigned as Chief Financial Officer and Treasurer, effective immediately on December 17, 2018.
- Interim CFO Engagement: Aleksey Krylov, a former CFO of the company, was engaged as a consultant to provide interim financial services for an initial three-month term at a fee of $17,250 per month.
- Appointment of Interim Principal Accounting Officer: John T. Burns, previously Vice President, Finance and Corporate Controller, was appointed as the interim principal accounting officer.
Management Commentary, Risks, and Unusual Items
The filing details the compensation structure for the newly appointed interim Principal Accounting Officer, John T. Burns:
- Base Salary: $235,000 per year.
- Annual Bonus: Eligible for up to 30% of base salary, at the Board's discretion.
- Severance: Upon termination without cause or resignation for good reason after 18 months of service, Mr. Burns is entitled to nine months of continuing severance pay equal to 100% of his base salary.
- Risks/Contingencies: No specific financial risks or contingencies were disclosed in this report. The filing notes that Mr. Burns has no family relationships with directors or other officers and no reportable related party transactions exist.
Investor Verification Checklist
- Verify the status of the search for a permanent Chief Financial Officer to assess leadership stability.
- Review the full text of the Employment Agreement (Exhibit 10.1) for additional terms regarding Mr. Burns' appointment.
- Monitor future filings for any financial restatements or delays in reporting that may result from the leadership transition.
- Confirm the duration and scope of Mr. Krylov's interim consulting role.